NASDAQ·Pharmaceutical Preparations

APREAprea Therapeutics, Inc.

Aprea Therapeutics, Inc. (APRE) has a auditor change flag.

Last filing: filing·May 13, 2026EDGAR ↗

APRE Risk Flags

Consolidated view of every risk_flag row APREhas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	high	10-K · Mar 26, 2024	PCAOB-tagged auditor in 10-K filed 2024-03-26 (accession 0001558370-24-003886) was 'EisnerAmper LLP' (PCAOB Firm ID: 274). Prior 10-K/A filed 2023-04-28 (accession 0001558370-23-007284) was 'Ernst & Young LLP' (PCAOB Firm ID: 42).	view ↗

Related on APRE

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.